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ABSTRACT
Herbal supplements, if taken at the same time as prescription medicines, can create potential problems for the
user. Unfortunately, there is very little scientific information available about the way herbs and drugs interact. The
present paper deals with various herbal supplements and their interactions with medications.
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INTRODUCTION
Iron is an essential mineral and an important component of proteins involved in oxygen transport and
metabolism. Iron is also an essential cofactor in the synthesis of neurotransmitters such as dopamine, norepinephrine,
and serotonin. About 15 percent of the body's iron is stored for future needs and mobilized when dietary intake is
inadequate. The body usually maintains normal iron status by controlling the amount of iron absorbed from food.
There are two forms of dietary iron: heme and non-heme. Sources of heme iron include meat fish and poultry.
Sources of non-heme iron, which is not absorbed as well as heme iron, include beans, lentils, flours, cereals, and
grain products. Other sources of iron include dried fruit, peas, asparagus, leafy greens, strawberries, and nuts.
The World Health Organization considers iron deficiency to be the largest international nutritional disorder.
Although much of the ethnic disparity in iron deficiency anemia remains unexplained, socioeconomic factors may be
involved. Iron deficiency can be determined by measurement of iron levels within the body, mainly serum ferritin
levels, which can also help distinguish between iron deficiency anemia and anemia associated with chronic disease.
Herbal preparations such as yellow dock root may be used in iron deficiency, although scientific evidence may be
lacking.
Adults (18 years and older):
The Recommended Dietary Allowance (RDA) for males (19- 50 years) is 8 milligrams per day; females (1950 years) 18 milligrams per day; adults (51 years and older) 8 milligrams per day; pregnant women (all ages) 27
milligrams per day; breastfeeding women (19 years and older) 9 milligrams per day.
The Tolerable Upper Intake Level (UL) for adults (19 years and older) is 45 milligrams per day.

The RDA for iron from a completely vegetarian diet should be adjusted as follows: 14 milligrams per day for
adult men and postmenopausal women, 33 milligrams per day for premenopausal women, and 26 milligrams per day
for adolescent girls.
Doses ranging from 60 to 180mg of elemental iron have been used for iron deficiency/anemia. Dextran-iron
(INFeD®) is given by healthcare providers to replenish depleted iron stores in the bone marrow where it is
incorporated into hemoglobin. The usual adult dose is 2 milliliters per day (100 milligrams iron).
Children (younger than 18 years):
The Recommended Dietary Allowance (RDA) is 11 milligrams for 7-12 months; 7 milligrams for 1-3 years;
10 milligrams for 4-8 years; 8 milligrams for 9-13 years (male and female); 11 milligrams for males 14-18 years; 15
milligrams for females 14-18 years; 27 milligrams for pregnant females 14-18 years; 10 milligrams for breastfeeding
females 14-18 years. For infants 0-6 months 0.27 milligrams is recommended as the adequate intake level (AI),
which is used when RDA cannot be determined.
The Tolerable Upper Intake Level (UL) for infants (1-12 months) is not possible to establish; children (1-13
years) 40 milligrams per day; adolescents (14-18 years) 45 milligrams per day.
Dextran-iron (INFeD®) is an intravenous preparation given by qualified healthcare provider to replenish
depleted iron stores in the bone marrow where it is incorporated into hemoglobin. Doses of 50 milligrams iron (1
milliliter) (5-10 kilograms) and 100 milligrams iron (2 milliliters) (10-50 kilograms) have been used.
Side Effects and Warnings
In general, people with a history of kidney disease, intestinal disease, peptic ulcer disease, enteritis, colitis,
pancreatitis, hepatitis, who consume excessive alcohol, plan to become pregnant, or are over age 55 and have a
family history of heart disease, should consult a doctor and pharmacist before taking iron.
Liquid oral iron preparations can possibly blacken teeth.
Acute overdosage or iron accumulation symptoms may include arthritis, signs of gonadal failure
(amenorrhea, early menopause, loss of libido, impotence), and shortness of breath/dyspnea. High doses may cause
vomiting and diarrhea, followed by cardiovascular or metabolic toxicity, and death. It is unclear whether high levels
are associated with cancer, coronary heart disease or myocardial infarction (MI).
Gastrointestinal upset including nausea, vomiting, constipation, diarrhea, and dark stools have been reported.
Gastrointestinal side effects are relatively common and corrective bowel regimens such as increasing dietary fiber or
over the counter medication might be recommended to balance these side effects. Supervision by a qualified
healthcare provider is recommended.
Individuals with blood disorders who require frequent blood transfusions are also at risk of iron overload and
should not take iron supplements without direction by a qualified healthcare provider. Long-term use of high doses
of iron can cause hemosiderosis that clinically resembles hemochromatosis.
HCV infection and iron loading may aggravate oxidative stress in dialysis patients.
Iron overload is associated with several genetic diseases including hemochromatosis (a defect in iron
metabolism with build up of iron in the body). The most commonly associated early hemochromatosis symptoms
include fatigue, weakness, weight loss, abdominal pain, and arthralgia.
A case of hypersiderosis (uncontrollable sweating) has been reported with long-term iron supplementation in

uremic patients treated with periodic dialysis.
Accumulation of excess iron is being investigated as a potential contributor to neurodegenerative diseases such as
Alzheimer's and Parkinson's disease.
Iron overload is possible in very low birth weight infants after multiple blood transfusions due to increase
liver iron concentration. Prenatal iron-overload might contribute to the pathogenesis of the disease, but further
studies are needed to confirm the assumption.
One study indicates that higher consumption of total red meat, especially various processed meats, may
increase risk of developing type 2 diabetes in women.
Pregnancy and Breastfeeding
Pregnant or breastfeeding women should seek guidance from a qualified healthcare provider before taking
dietary supplements. Iron status of the pregnant woman should be measured early (before the 15th week of
gestation) and iron supplements should be given as selective prophylaxis based on the serum ferritin level.
FDA Pregnancy Category B: Usually safe but benefits must outweigh the risks.
FDA Pregnancy Category C: Safety for use during pregnancy has not been established for replenishing depleted iron
stores in the bone marrow where it is incorporated into hemoglobin.
INTERACTIONS
Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements,
drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments,
or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs,
herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.
Interactions with Drugs
Acetohydroxamic acid (AHA, Lithostat®) is prescribed to decrease urinary ammonia, and may help with
antibiotics to work or help with other kidney stone treatment. Use with iron supplements may cause either medicine
to be less effective.
Allopurinol (Zyloprim®), a medication used to treat gout, may increase iron storage in the liver and should not be
used in combination with iron supplements.
Aminosalicylic acid (para-aminosalicylic acid, PAS, Paser) may cause a malabsorption syndrome (weight loss, iron
and vitamin depletion, excessive fat in the stools (steatorrhea). A qualified healthcare provider should be contacted
immediately if any of these symptoms are experienced.
Antacids may reduce iron absorption, and reduced efficacy has occurred occasionally. Clinically significant
effects are unlikely with adequate dietary iron intake. However, it is recommended to avoid antacids or separate the
doses of antacids and iron.
Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) can cause mucosal damage and bleeding throughout
the gastrointestinal tract. Chronic blood loss associated with long-term use of these agents may contribute to iron
deficiency anemia. Since iron supplements may also irritate the gastrointestinal tract, patients should not use them
concurrently with NSAIDs unless recommended by a physician. Iron rich food intake may be advised as an
alternative.
Iron can decrease absorption of prescription drug bisphosphonates by forming insoluble complexes.

Bisphosphonates include alendronate (Fosamax®), etidronate (Didronel®), risedronate (Actonel®), and tiludronate
(Skelid®). Doses of bisphosphonates should be separated by at least two hours from doses of all other medications,
including supplements such as iron.
Chloramphenicol (Chloromycetin®) can reduce the response to iron therapy in iron deficiency anemia.
Cholestyramine (Questran®) and colestipol (Colestid®) may bind iron in the gut, reducing its absorption.
Clinically significant iron deficiency induced by these drugs has not been reported, and supplements are not likely to
be needed. If taking iron supplements for other causes of deficiency, it is recommended that the iron and
cholestyramine or colestipol doses be separated by at least four hours.
Desferrioxamine (DFO) is an iron-chelating drug that lowers iron levels.
Iron supplements and dimercaprol may combine in the body to form a harmful chemical.
Bone marrow iron deposits have been shown to decrease significantly in patients on EPO-R.
Iron decreases the absorption of fluoroquinolone antibiotics. Fluoroquinolones include ciprofloxacin
(Cipro®), levofloxacin (Levaquin®), ofloxacin (Floxin®), and others. It is recommended to take these antibiotics at
least two hours before or two hours after iron-containing supplements.
Gastric acid is important for the absorption of iron, particularly dietary non-heme (plant-derived) iron.
Adequate dietary iron intake is recommended when taking H2 blockers like cimetidine (Tagamet®), ranitidine
(Zantac®), famotidine (Pepcid®), or nizatidine (Axid®). Iron supplements are not usually required unless they are
being used for another indication.
There is some evidence in healthy people that iron forms chelates with levodopa (Sinemet®), reducing the
amount of levodopa absorbed by around 50%. Until further research is available, separate doses of levodopa and iron
as much as possible.
Iron can decrease the absorption and efficacy of levothyroxine (Levoxyl®, Synthroid®) by forming insoluble
complexes in the gastrointestinal tract. It is recommended that levothyroxine and iron doses be separated by at least
two hours.
Iron can decrease absorption of methyldopa (Aldomet®), resulting in increases in blood pressure. It is
recommended that methyldopa and iron doses be separated by at least two hours.
Oral iron supplements markedly reduce absorption of mycophenolate mofetil (CellCept®). It is recommended
that iron be taken four to six hours before, or two hours after mycophenolate mofetil.
There is some evidence that pancreatic enzyme supplements (such as Cotazym®, Creon®, Pancrease®,
Ultrase®, Viokase®), can reduce iron absorption, possibly by binding iron or altering pH. Clinical significance is
unlikely, except in people with cystic fibrosis who need pancreatic enzyme supplements for prolonged periods, and
have other factors contributing to iron deficiency. Iron status should be monitored by a qualified healthcare provider.
Oral iron supplements can reduce absorption of penicillamine (Cuprimine®, Depen®) by 30% to 70%,
probably due to chelate formation. Efficacy of penicillamine is reduced in Wilson's disease; the clinical significance
in people with rheumatoid arthritis (RA) has not been determined. Patients should be advised to take penicillamine at
least two hours before or after iron-containing supplements.
Gastric acid is important for the absorption of iron. However, long-term treatment, up to 12.5 years, with
proton pump inhibitors (such as esomeprazole (Nexium®), lansoprazole (Prevacid®), omeprazole (Prilosec®),
rabeprazole (Aciphex®), pantoprazole (Protonix®, Pantoloc®) has not been associated with iron depletion or
anemia in people with normal iron stores. Maintaining adequate dietary iron intake is recommended.

Concomitant use can decrease absorption of tetracycline antibiotics by 50% to 90%. Patients should be
advised to take tetracyclines at least two hours before or after iron-containing supplements. Some of these drugs
include doxycycline (Vibramycin®), minocycline (Minocin®), tetracycline (Achromycin®), and others.
Interactions with Herbs and Dietary Supplements
Acacia forms an insoluble gel with ferric iron. Clinical significance is unknown.
Calcium supplements have been shown to inhibit absorption of iron supplements when taken with food. However, in
people with adequate iron stores, this does not appear to be clinically significant. If at risk for iron deficiency, it is
recommended to take calcium supplements at bedtime, instead of with meals, to avoid inhibiting dietary iron
absorption.
Copper metabolism may be altered by iron supplements, but the clinical importance of this observation is unknown.
Citric, malic, tartaric, and lactic acids have some enhancing effects on nonheme iron absorption.
Phytic acid is present in legumes, grains, and rice and is an inhibitor of nonheme iron absorption. Small
amounts of phytic acid can reduce nonheme iron absorption by 50%. The absorption of iron from legumes, such as
soybeans, black beans, lentils, mung beans, and split peas, has been shown to be as low as 2%.
Polyphenols, found in some fruits, vegetables, coffee, tea, wines, and spices, can markedly inhibit the
absorption of nonheme iron. This effect is reduced by the presence of vitamin C.
Riboflavin (vitamin B2) supplements may improve the hematological response to iron supplements in some
people with anemia.
Based on preliminary data, iron may decrease selenium levels. Further research is needed to confirm these results.
Soy protein reduces absorption of dietary non-heme (plant-derived) iron, probably due to binding of iron by
phytate and calcium present in soy. Fermented soy products seem to inhibit of iron absorption less.
Vitamin A appears to be involved in mobilizing iron from tissue stores for delivery to developing red blood
cells in the bone marrow. Vitamin A may also be involved in the differentiation and proliferation of blood stem cells
in the bone marrow, and in the synthesis of erythropoietin. Preliminary evidence also suggests that vitamin A and
beta-carotene may enhance non-heme iron absorption from iron-fortified wheat and corn flour, and rice. It is
unlikely that vitamin A supplements would have significant effects on iron status in people without vitamin A
deficiency.
The amount of vitamin C in the diet is a factor in dietary iron absorption and iron status. Vitamin C can
counteract the effects of substances, which inhibit iron absorption. Supplemental or dietary vitamin C improves
absorption of supplemental or dietary non-heme (plant-derived) iron ingested at the same time. Taking a vitamin C
supplement to improve absorption of dietary or supplemental iron probably is not necessary for most people,
especially if their diet contains adequate amounts of vitamin C.
Use of oral iron preparations in premature infants with low serum vitamin E levels may cause hemolysis and
hemolytic anemia. Vitamin E deficiency should be corrected before administering supplemental iron.
Iron may decrease zinc absorption but there does not seem to be a clinically significant interaction between
dietary iron and zinc, or between supplemental iron and zinc dietary sources.

Herbal
Common Uses
Supplement

Possible Problems

May Interact With

Dong Quai
(Angelica)

To treat menopausal Enhances bleeding.
symptoms, PMS,
irregular
menstruation cycles.
Echinacea To treat colds, flu,
May cause injury to the liver; may
and mild infections, cause intestinal/ stomach upset.
especially upper
respiratory infections
(chest colds).
Ephedra
To treat asthma and May cause seizures; may cause
(Ma Huang, coughs; to stimulate adverse cardiac events, such as
Ephedrine, weight loss.
irregular heartbeat, high blood
Pseudopressure, stroke, or heart attack.
ephedrine)
Garlic
To decrease
Enhances bleeding.
cholesterol and blood
clot formation.
Ginger
To relieve nausea.
Enhances bleeding; may affect the
central nervous system; may lower
blood pressure; may cause
irregular heartbeat; may lower
blood glucose levels.
Ginkgo
To improve
Enhances bleeding; may cause
Biloba
circulation,
cramps and/or muscle spasms.
especially to brain;
also for memory loss,
dizziness, and
headache.
Ginseng
To increase energy Enhances bleeding; may cause
and reduce stress.
irregular heartbeat and/or increase
blood pressure; may cause mania.

Goldenseal Used as a mild
antibiotic to treat
sore throats and
upper respiratory
infections.
Kava Kava To treat anxiety,
nervousness, and
insomnia.

Drugs that hinder the clotting of blood.

Drugs that may cause injury to the liver;
synthetic hormones; some anti-cancer
drugs.

Some heart medications; general
anesthesia; some antidepressants; medicines
that increase blood pressure; decongestants;
stimulants.
Drugs that hinder the clotting of blood.

Drugs that hinder the clotting of blood;
medicines that increase blood pressure;
cardiac drugs; drugs that lower blood sugar
level; may increase the effects of sedatives.
Drugs that hinder the clotting of blood.

Drugs that hinder the clotting of blood;
stimulants; medicines that lower blood
pressure; some antidepressants; digoxin (a
heart drug); may increase the effects of
steroids and estrogens.
Increases fluid retention; may
Drugs that increase urination; medicines
increase blood pressure; may cause that lower blood pressure.
nausea or nervousness.

May cause upset stomach; may
May increase the effects of sedatives,
cause liver damage and/or
muscle relaxants, anesthetics, and
stimulate an allergic skin reaction antidepressants.
that causes a yellow discoloration
of skin.
Licorice
To treat hepatitis and May increase blood pressure; may Medicines that lower blood pressure; may
peptic ulcers.
lower levels of potassium in the
increase the effects of steroids.
blood; may cause swelling.
SAM-e
To treat depression May induce drowsiness; may cause May increase the effects of some
(S-adenosyl- or osteoarthritis.
nausea and/or upset stomach.
antidepressants.
Lmethionine)
St. John's To treat mild
Enhances bleeding.
May increase the effects of anti-

Wort

Valerian

depression, anxiety,
depressants; decreases the effectiveness of
or seasonal affective
medications given to organ-transplant
disorder.
patients.
To treat insomnia or May induce drowsiness; may cause Enhances the effects of sedatives.
anxiety.
digestion problems.

CONCLUSIONS
Herbs are the vital sources in treating any diseases specially the disorders related to that of iron. The present
paper review a comprehensive details on the herbal haematanics and their interaction with that of various available
drugs. The table presented above indicates the uses of several herbs and the possible interaction’s they caused.
Hence, the present work will enlightens all the aspects of herbal haematanics and their interactions during the
medications.

REFERENCES
1. Beard JL. Iron deficiency: assessment during pregnancy and its importance in pregnant adolescents. Am.J.Clin
Nutr. 1994; 59(2 Suppl):502S-508S.
2. Black DA, Fraser C. M. Iron deficiency anaemia and aspirin use in old age. Br.J.Gen.Pract. 1999;49(446):729730.
3. Black MM, Baqui AH, Zaman K, et al. Iron and zinc supplementation promote motor development and
exploratory behavior among Bangladeshi infants. Am.J.Clin.Nutr. 2004;80(4):903-910.
4. Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effects of iron supplementation in
non-anaemic iron-deficient adolescent girls. Lancet 10-12-1996;348(9033):992-996.
5. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with
hypothyroidism. Ann.Intern.Med. 12-15-1992;117(12):1010-1013.
6. Chimonas MA, Baggett HC, Parkinson AJ, et al. Asymptomatic Helicobacter pylori infection and iron deficiency
are not associated with decreased growth among Alaska Native children aged 7-11 years. Helicobacter. 2006
Jun;11(3):159-67.
7. Cogswell ME, Parvanta I, Ickes L, et al. Iron supplementation during pregnancy, anemia, and birth weight: a
randomized controlled trial. Am.J.Clin.Nutr. 2003;78(4):773-781.
8. Dawson B, Goodman C, Blee T, et al. Iron supplementation: oral tablets versus intramuscular injection. Int J
Sport Nutr Exerc Metab. 2006 Apr;16(2):180-6.
9. Makrides M, Crowther CA, Gibson RA, et al. Efficacy and tolerability of low-dose iron supplements during
pregnancy: a randomized controlled trial. Am.J.Clin.Nutr. 2003;78(1):145-153..
10. Milman N, Bergholt T, Eriksen L, et al. Iron prophylaxis during pregnancy -- how much iron is needed? A
randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women. Acta
Obstet.Gynecol.Scand. 2005;84(3):238-247.
11. Radtke H, Tegtmeier J, Rocker L, et al. Daily doses of 20 mg of elemental iron compensate for iron loss in
regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004;44(10):14271432.
12. Schroder O, Schrott M, Blumenstein I, et al. A study for the evaluation of safety and tolerability of intravenous
high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. Z.Gastroenterol.
2004;42(8):663-667.
13. Weatherall M, Maling TJ. Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial.
ANZ.J.Surg. 2004;74(12):1049-1051.
14. Zhou SJ, Gibson RA, Crowther CA, et al. Effect of iron supplementation during pregnancy on the intelligence
quotient and behavior of children at 4 y of age: long-term follow-up of a randomized controlled trial. Am J Clin
Nutr. 2006 May;83(5):1112-7.
15. Zimmermann MB, Muthayya S, Moretti D, et al. Iron fortification reduces blood lead levels in children in
Bangalore, India. Pediatrics. 2006 Jun;117(6):2014-21.
16. University of Maryland Medicine, Iron-deficiency Anemia, 2003 University of Maryland Medical System,

http://www.umm.edu/blood/aneiron.htm
17. Medline Plus, Iron in diet, 2003 U.S. National Library of Medicine and National Institutes of Health
http://www.nlm.nih.gov/medlineplus/ency/article/002422.htm
18. State Administration of Traditional Chinese Medicine, Advanced Textbook on Traditional Chinese Medicine and
Pharmacology, (vol. 1) 1995-6 New World Press, Beijing
19. Wang Qi and Dong Zhi Lin, New Practical Syndrome Differentiation of T.C.M., 1992 China Ocean Press,
Beijing.
20. Cheung CS and Belluomini J, Blood, Journal of the American College of Traditional Chinese Medicine 1982 (2):
48-54.
21. McKinley Health Center, Dietary Sources of Iron, 2001 University of Illinois;
http://www.mckinley.uiuc.edu/handouts/dietiron.html
22. Dharmananda S, Bag of Pearls, 2002/2003 Institute for Traditional Medicine, Portland, OR.

